PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2020-05-20

Date Title Company
20-May-2020 Vanda Pharmaceuticals Wins Motion To Dismiss False Claims Act Lawsuit Vanda Pharmaceuticals Inc.
20-May-2020 China Biologic Reports Financial Results for the First Quarter of 2020 China Biologic Products Holdings, Inc.
20-May-2020 NeuroBo Pharmaceuticals Reports First Quarter 2020 Financial Results NeuroBo Pharmaceuticals, Inc.
20-May-2020 Genespire and SR-Tiget announce strategic alliance for the development of transformative gene therapies for genetic diseases and disclose collaboration focus The San Raffaele Telethon
20-May-2020 Oxford Biomedica receives MHRA approval for the first two manufacturing suites in Oxbox Oxford Biomedica
20-May-2020 Novadip Biosciences Reports Positive Interim Analysis of Phase I/II Bone Non-Union Study with NVD003 Novadip Biosciences
20-May-2020 BioMed X Institute Launches Rapid Antiviral Response Platform to Prevent Future Pandemics BioMed X
20-May-2020 Europlaz Technologies Ltd secures contract to manufacture COVID-19 Test Kits Europlaz Technologies Ltd
20-May-2020 Alphega Pharmacy Members Receive Extra Support in Covid-19 Effort Alphega Pharmacy
20-May-2020 Prime Global announces acquisition of Cambridge Medical Communication Prime Global
20-May-2020 Minoryx Therapeutics doses first patient with leriglitazone in registration-enabling cALD NEXUS trial Minoryx Therapeutics
20-May-2020 BARDA Provides the Sabin Vaccine Institute with an Additional $20 Million for Further Development of Ebola Sudan and Marburg Vaccines The Sabin Vaccine Institute (Sabin)
20-May-2020 Ori Biotech and CellGenix to collaborate in order to promote innovation within closed-system cell and gene therapy manufacturing Ori Biotech
20-May-2020 Leica Microsystems Donate an Advanced Microscopy System to Charité’s Institute of Virology to Progress Covid-19 Research Leica Microsystems
20-May-2020 Why research on ticks could offer potential COVID-19 breakthrough ILC Therapeutics
20-May-2020 European Commission Approves Subcutaneous Formulation of Entyvio® (Vedolizumab) for use as Maintenance Therapy in Adults with Moderately to Severely Active Ulcerative Colitis or Crohn’s Disease Takeda Pharmaceutical Company Limited
20-May-2020 ASLAN PHARMACEUTICALS REPORTS FIRST QUARTER 2020 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE ASLAN Pharmaceuticals
20-May-2020 4D Pharma: successful completion of immuno-oncology study safety phase 4D pharma plc
20-May-2020 New COVID-19 Antibody Testing Partnership Quotient Limited and hVIVO Announce Partnership to Support Wide-Spread COVID-19 Antibody Testing in the UK Open Orphan plc
20-May-2020 HUMMINGBIRD BIOSCIENCE CLOSES US$25 MILLION INVESTMENT WITH SERIES B EXTENSION Hummingbird Bioscience